» Articles » PMID: 35360835

Receptiveness of American Adults to COVID-19 Vaccine Boosters: A Survey Analysis

Overview
Journal PEC Innov
Specialty Health Services
Date 2022 Apr 1
PMID 35360835
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This Short Communication report summarizes results from a recent survey on the willingness of American adults to accept COVID-19 vaccine boosters. We seek to identify evolving hesitancies and objections to booster shots among those who previously accepted vaccination.

Methods: A representative, web-based survey of 600 adults in the State of Florida was fielded, and the results are analyzed using both descriptive and inferential statistical methods.

Results: The survey responses show that while booster shot hesitancy is relatively low among vaccinated Americans, nearly a third (30.4%) say that they are only somewhat likely or less to receive a vaccine booster shot. Statistical analysis shows that trust in public health guidance is the driving factor behind booster shot hesitancy, while significant differences also exist based on race and level of education. The most frequently cited objections to booster shots include concerns over the necessity of additional shots and adverse reactions to the initial vaccination.

Conclusion: Objections to booster shots highlight emerging communications challenges that health professional will need to consider and address as vaccine guidance continues to evolve.

Innovation: This study contributes to innovation in health communications by identifying emerging challenges and barriers in the ongoing effort to promote COVID-19 vaccination.

Citing Articles

Exploring the relationship between experience of vaccine adverse events and vaccine hesitancy: A scoping review.

Gauna F, Raude J, Khouri C, Cracowski J, Ward J Hum Vaccin Immunother. 2025; 21(1):2471225.

PMID: 40058398 PMC: 11901385. DOI: 10.1080/21645515.2025.2471225.


Acceptance of COVID-19 vaccine booster doses among the Adult Population in Ghana: a cross-sectional study using the Health Belief Model.

Eshun G, Kyei-Arthur F, Abdou M, Agyekum M, Sarfo M, Agbenyeavu J BMC Public Health. 2024; 24(1):2673.

PMID: 39350125 PMC: 11440929. DOI: 10.1186/s12889-024-20201-9.


Messaging to Reduce Booster Hesitancy among the Fully Vaccinated.

Qin C, Joslyn S, Han J, Savelli S, Agrawal N Vaccines (Basel). 2024; 12(9).

PMID: 39340096 PMC: 11436094. DOI: 10.3390/vaccines12091066.


Acceptability of COVID-19 booster vaccine in malaysia: a cross-sectional study.

Khoo C, Dea E, Law L, Wong S, Ng K, Bakhtiar A Sci Rep. 2024; 14(1):8421.

PMID: 38600166 PMC: 11006945. DOI: 10.1038/s41598-024-59195-0.


Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review.

Nath Roy D, Ferdiousi N, Hossen M, Islam E, Azam M Vaccine X. 2024; 18:100480.

PMID: 38585380 PMC: 10997838. DOI: 10.1016/j.jvacx.2024.100480.


References
1.
Wilkinson E, Jetty A, Petterson S, Jabbarpour Y, Westfall J . Primary Care's Historic Role in Vaccination and Potential Role in COVID-19 Immunization Programs. Ann Fam Med. 2021; 19(4):351-355. PMC: 8282305. DOI: 10.1370/afm.2679. View

2.
Kricorian K, Turner K . COVID-19 Vaccine Acceptance and Beliefs among Black and Hispanic Americans. PLoS One. 2021; 16(8):e0256122. PMC: 8384224. DOI: 10.1371/journal.pone.0256122. View

3.
Momplaisir F, Kuter B, Ghadimi F, Browne S, Nkwihoreze H, Feemster K . Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals. JAMA Netw Open. 2021; 4(8):e2121931. PMC: 8406078. DOI: 10.1001/jamanetworkopen.2021.21931. View

4.
Neely S, Eldredge C, Ersing R, Remington C . Vaccine Hesitancy and Exposure to Misinformation: a Survey Analysis. J Gen Intern Med. 2021; 37(1):179-187. PMC: 8528483. DOI: 10.1007/s11606-021-07171-z. View